Log in to save to my catalogue

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairme...

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairme...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5549436

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

About this item

Full title

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Cannabis and cannabinoid research, 2016-01, Vol.1 (1), p.81-89

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

We recently uncovered a signaling mechanism by which the endocannabinoid anandamide mediates the action of oxytocin, a neuropeptide that is crucial for social behavior, to control social reward. Oxytocin signaling has been implicated in autism spectrum disorder (ASD), and social reward is a key aspect of social functioning that is thought to be dis...

Alternative Titles

Full title

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5549436

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5549436

Other Identifiers

ISSN

2378-8763,2578-5125

E-ISSN

2378-8763

DOI

10.1089/can.2015.0008

How to access this item